101 related articles for article (PubMed ID: 15973992)
21. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells.
Tran CP; Lin C; Yamashiro J; Reiter RE
Mol Cancer Res; 2002 Dec; 1(2):113-21. PubMed ID: 12496358
[TBL] [Abstract][Full Text] [Related]
22. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
World J Surg Oncol; 2004 May; 2():13. PubMed ID: 15132743
[TBL] [Abstract][Full Text] [Related]
23. Prostate stem cell antigen (PSCA) mRNA expression in prostatic intraepithelial neoplasia: implications for the development of prostate cancer.
Zhigang Z; Wenlu S
Prostate; 2007 Aug; 67(11):1143-51. PubMed ID: 17503471
[TBL] [Abstract][Full Text] [Related]
24. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
25. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer.
Han KR; Seligson DB; Liu X; Horvath S; Shintaku PI; Thomas GV; Said JW; Reiter RE
J Urol; 2004 Mar; 171(3):1117-21. PubMed ID: 14767283
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens.
Cheng L; Reiter RE; Jin Y; Sharon H; Wieder J; Lane TF; Rao J
J Urol; 2003 Jun; 169(6):2094-100. PubMed ID: 12771726
[TBL] [Abstract][Full Text] [Related]
27. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
[TBL] [Abstract][Full Text] [Related]
28. [Prokaryotic expression, purification and antigenicity identification of mouse prostate stem cell antigen].
Dong J; Luo J; Yan J; Zhang L; Gao J; Yu J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):502-6. PubMed ID: 22543130
[TBL] [Abstract][Full Text] [Related]
29. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
[TBL] [Abstract][Full Text] [Related]
30. A novel peptide isolated from phage display peptides library recognized by an antibody against connective tissue growth factor (CTGF).
Liu N; Wu G; Li H; Li L; Xing H; Zhang C; Lu H
Int Immunopharmacol; 2009 Mar; 9(3):291-7. PubMed ID: 19103307
[TBL] [Abstract][Full Text] [Related]
31. [Cloning and expression of human single-chain Fv antibody against amyloid beta peptide involved in Alzheimer's disease].
Cai J; Wang SZ; Peng Y; Zhong YW; Ji ZJ; Yuan JG; Qiang BQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):557-62. PubMed ID: 14650158
[TBL] [Abstract][Full Text] [Related]
32. Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer.
Foss CA; Fox JJ; Feldmann G; Maitra A; Iacobuzio-Donohue C; Kern SE; Hruban R; Pomper MG
Mol Imaging; 2007; 6(2):131-9. PubMed ID: 17445507
[TBL] [Abstract][Full Text] [Related]
33. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
Zhigang Z; Wenlu S
Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
[TBL] [Abstract][Full Text] [Related]
34. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
35. [Generation of anti-rhEPO ScFv by using phage display technology].
Zhong L; Wu S; Yang X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):38-42. PubMed ID: 12515169
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patients.
Tanaka M; Komatsu N; Terakawa N; Yanagimoto Y; Oka M; Sasada T; Mine T; Gouhara S; Shichijo S; Okuda S; Itoh K
Oncol Rep; 2007 Jul; 18(1):161-6. PubMed ID: 17549363
[TBL] [Abstract][Full Text] [Related]
37. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
[TBL] [Abstract][Full Text] [Related]
38. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
[TBL] [Abstract][Full Text] [Related]
39. The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells.
Chizari M; Fani-Kheshti S; Taeb J; Farajollahi MM; Mohsenzadegan M
Recent Pat Anticancer Drug Discov; 2021; 16(1):73-83. PubMed ID: 33176663
[TBL] [Abstract][Full Text] [Related]
40. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
Katzenwadel A; Schleer H; Gierschner D; Wetterauer U; Elsässer-Beile U
Anticancer Res; 2000; 20(3A):1551-5. PubMed ID: 10928069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]